ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MXCT Maxcyte Inc

313.00
0.00 (0.00%)
Apr 19 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Maxcyte Inc MXCT London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 313.00 02:00:00
Open Price Low Price High Price Close Price Previous Close
313.00 313.00 313.00 313.00 313.00
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Recent News

Date Time Source Heading
4/10/202407:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
4/10/202407:05UK RNSMaxCyte, Inc. Notice of Results
4/03/202401:00UK RNSMaxCyte, Inc. Total Voting Rights and Block Listing Return
4/02/202409:19ALNCNewsTRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian..
4/02/202407:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
4/02/202407:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
4/02/202401:00UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
3/20/202405:16UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
3/20/202405:05UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
3/13/202406:54ALNCNewsIN BRIEF: MaxCyte loss widens in 2023 as core revenue..
3/13/202402:05UK RNSMaxCyte, Inc. Filing of form 10-K for FY ended December 31,..
3/13/202402:00UK RNSMaxCyte, Inc. Reports Q4 & FY 2023 Financial Results
3/12/202415:05UKREGMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
3/06/202402:58UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
3/05/202414:43ALNCNewsEARNINGS: dotdigital eyes rosy future; Beeks Financial turns..
3/05/202401:00UK RNSMaxCyte, Inc. Preliminary FY Results & 2024 Guidance
3/04/202415:05UKREGMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
3/01/202411:57UK RNSMaxCyte, Inc. Total Voting Rights
2/29/202403:21UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
2/26/202401:00UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
2/09/202407:05UK RNSMaxCyte, Inc. Notice of Results
2/09/202407:05UKREGMaxCyte to Report Fourth Quarter and Full Year 2023..
2/01/202403:24UK RNSMaxCyte, Inc. Total Voting Rights
1/31/202401:00UK RNSMaxCyte, Inc. Director/PDMR Shareholding
1/30/202408:29UK RNSMaxCyte, Inc. Holding(s) in Company
1/30/202407:58ALNCNewsIN BRIEF: MaxCyte signs licencing deal with cell therapy..
1/30/202407:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
1/30/202407:05UKREGMaxCyte and Wugen Sign Strategic Platform License to..
1/29/202411:56ALNCNewsIN BRIEF: MaxCyte chief scientific officer leaves firm
1/29/202410:52UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
1/29/202401:00UK RNSMaxCyte, Inc. Filing of Form 8-K
1/23/202412:39ALNCNewsTRADING UPDATES: Esken's Southend Airport faces further..
1/23/202407:05UKREGMaxCyte, Inc. Signing of Strategic Platform License
1/23/202407:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
1/09/202406:18ALNCNewsMaxCyte's strategic platform licences redeem otherwise..
1/09/202401:00UKREGMaxCyte, Inc. Preliminary Unaudited Q4 and FY 2023 Results
1/08/202415:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..
1/05/202401:00UKREGMaxCyte, Inc. Grant of Options and PDMR Dealing
1/03/202408:04ALNCNewsMaxCyte teams with Singapore-based Lion to support TCR-T..
1/03/202407:05GLOBEMaxCyte and Lion TCR form Partnership to Support Global..
1/03/202407:05UKREGMaxCyte, Inc. Signing of Strategic Platform License
1/02/202403:23UKREGMaxCyte, Inc. Total Voting Rights
1/02/202401:00GLOBEMaxCyte Confirms Appointment of Maher Masoud as President,..
1/02/202401:00UKREGMaxCyte, Inc. Confirmation of Board change
12/29/202301:00UKREGMaxCyte, Inc. Exercise of options and PDMR dealing
12/12/202309:56ALNCNewsTRADING UPDATES: Technology Minerals identifies lithium at..
12/12/202301:00UKREGMaxCyte, Inc. CEO Transition and Revenue Guidance Update
12/11/202315:05GLOBEMaxCyte Announces CEO Transition and Updates Revenue..
12/07/202303:50UKREGMaxCyte, Inc. Exercise of options and PDMR dealing
12/04/202301:00UKREGMaxCyte, Inc. Exercise of options and PDMR dealing

Your Recent History

Delayed Upgrade Clock